For the year ending 2025-12-31, OMER had $6,260K increase in cash & cash equivalents over the period. -$116,159K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -3,350 |
| Gain on sale of zaltenibart | 237,594 |
| Remeasurement on fair value of financial instruments | -136,717 |
| Stock-based compensation expense | 8,192 |
| Depreciation and amortization | 964 |
| (gain) loss on early extinguishment of debt-Convertible Senior Notes2026 | -2,968 |
| Amortization of discount and issuance costs on debt-Convertible Debt | 3,945 |
| Amortization of discount and issuance costs on debt-Initial Term Loan | -5,578 |
| (gain) loss on early extinguishment of debt-Initial Term Loan | 20,579 |
| Non-cash interest remeasurement on the omidria royalty obligation | -33,435 |
| Non-cash interest on omidria contract royalty asset | 14,717 |
| Remeasurement on omidria contract royalty asset | 12,657 |
| Accretion on u.s. government treasury bills, net | 0 |
| Omidria contract royalty asset | -33,623 |
| Accounts payable and accrued expense | 4,582 |
| Receivables | 3,178 |
| Prepaid expenses and other | 1,311 |
| Net cash provided by (used in) operating activities | -116,094 |
| Gross cash proceeds from sale of zaltenibart | 240,000 |
| Proceeds from the sale and maturities of investments | 109,900 |
| Purchases of investments | 185,312 |
| Purchases of property and equipment | 65 |
| Net cash provided by investing activities | 164,523 |
| Proceeds from registered offering, net-Securities Purchase Agreement With Polar Asset Management | 20,327 |
| Proceeds from registered offering, net-At The Market Equity Offering Program | 19,016 |
| Proceeds upon exercise of stock options | 7,651 |
| Repayment of term debt principal | 67,077 |
| Principal payments on omidria royalty obligation | 14,956 |
| Prepayment premium and transaction costs on repayment of term debt-Initial Term Loan | 3,544 |
| Payment of debt issuance costs related to 2029 notes-The2029Notes | 2,837 |
| Payments on finance lease obligations | 749 |
| Proceeds from sale of future royalties | 0 |
| Payment on maturity of 2023 notes | 0 |
| Cash paid to repurchase 2026 notes | 0 |
| Repurchases of common stock | 0 |
| Net cash provided by (used in) financing activities | -42,169 |
| Net increase (decrease) in cash and cash equivalents | 6,260 |
| Cash and cash equivalents at beginning of period | 3,400 |
| Cash and cash equivalents at end of period | 9,660 |
OMEROS CORP (OMER)
OMEROS CORP (OMER)